Google
Trusted Resources: News & Events
Latest announcements and gatherings
NFL Broadcaster Solomon Wilcots and Emmaus Life Sciences Kick Off “Sideline Sickle Cell” Campaign during National Minority Health Month
Emmy Award-winning NFL broadcaster Solomon Wilcots and Emmaus Life Sciences, Inc. today announced the launch of Sideline Sickle Cell, an educational campaign designed to raise awareness and drive discussion about recent and future treatment innovations for sickle cell disease (SCD) among physicians, patients and their family members as well as other members of the SCD community in the United States.
The campaign launch, which coincides with the start of National Minority Health Month, will include a national media tour led by Wilcots followed by a series of local market media relations activities and town hall-type meetings that bring together members of the disease community. Sideline Sickle Cell event markets will include Los Angeles, New York, Miami, Atlanta and others as the campaign rolls out in 2019. People can follow the campaign and join the conversation by connecting with @EmmausLifeSci on Twitter and using the hashtag #SidelineSickleCell.
+myBinderRelated Content
-
Under The Radar: Sickle Cell DiseaseIn the U.S., an estimated 100,000 Americ...
-
Sickle Cell and School: A Guide to School Policy and Best PracticesSickle cell disease (SCD) is a collectiv...
-
SCDAA Partners With Phi Beta Sigma FraternityThe Sickle Cell Disease Association of A...
-
What’s in your genes?https://www.youtube.com/watch?v=ggeqOj07...
-
Debra FigginsDebra Figgins is a Sickle Cell Educator....
-
Have A Heart for Sickle Cell Anemia FoundationThe Have A Heart for Sickle Cell Anemia ...
-
2020 RARE on the Road – RaleighThe EveryLife Foundation for Rare Diseas...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.